Research and Markets: Global Ischemic Stroke Therapeutics Pipeline Review, H2 2015
November 27 2015 - 9:05PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/4hb5rg/ischemic_stroke)
has announced the addition of the "Ischemic Stroke - Pipeline
Review, H2 2015" report to their offering.
This report provides comprehensive information on the
therapeutic development for Ischemic Stroke, complete with
comparative analysis at various stages, therapeutics assessment by
drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in
the therapeutic development for Ischemic Stroke and special
features on late-stage and discontinued projects.
The report enhances decision-making capabilities and helps to
create effective counter strategies to gain competitive advantage.
It strengthens R&D pipelines by identifying new targets and
MoAs to produce first-in-class and best-in-class products.
Companies Involved in Therapeutics Development
- AB Science SA
- Acticor Biotech
- advanceCor GmbH
- Angion Biomedica Corp.
- AstraZeneca Plc
- Athersys, Inc.
- biOasis Technologies Inc.
- Biogen, Inc.
- BioTime, Inc.
- D-Pharm Ltd.
- Daiichi Sankyo Company, Limited
- DiaMedica Inc.
- Digna Biotech, S.L.
- Genervon Biopharmaceuticals, LLC
- Glialogix, Inc.
- Glucox Biotech AB
- Grifols, S.A.
- Huons Co., Ltd.
- International Stem Cell Corporation
- JN-International Medical Corporation
- Laboratoires Pierre Fabre SA
- Lumosa Therapeutics Co., Ltd.
- MediaPharma s.r.l.
- Mitsubishi Tanabe Pharma Corporation
- Neuralstem, Inc.
- Neurotec Pharma SL
- NeuroVive Pharmaceutical AB
- NoNO, Inc.
- Panacea Pharmaceuticals, Inc.
- Pharmicell Co., Ltd.
- PhytoHealth Corporation
- Remedy Pharmaceuticals, Inc.
- ReNeuron Group Plc
- SanBio, Inc.
- Virogenomics, Inc.
For more information visit
http://www.researchandmarkets.com/research/4hb5rg/ischemic_stroke
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151127005412/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Cardiovascular, Central Nervous
System